Atara Biotherapeutics Inc
ATRAHealthcare|Biotechnology|USA
$9.72
-0.26 (-2.59%)
Upcoming Data Readouts (1)
Sep 2026
Est. completion
P1Malignant Pleural Mesothelioma (MPM)
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
NCT04577326n=14